Hologic's results suffer from weak bone densitometry market
This article was originally published in Clinica
Executive Summary
Hologic's total annual revenues fell by 27% to $84.1 million as the imaging company's core business, bone densitometry, suffered from continuing weak demand. In particular, it experienced lower than expected sales of its Sahara ultrasound bone sonometer.